Funding This work was supported by the European Community under Innovative Medicines Initiative (IMI) Program (Grant No
It influences sleep through several interconnected pathways: Delta wave enhancement: DSIP increases the amplitude and duration of delta waves during Stage 3 NREM sleep, extending the most restorative phase of sleep Circadian rhythm modulation: DSIP interacts with the body's internal clock mechanisms, helping to normalize disrupted sleep-wake patterns Cortisol regulation: DSIP has been shown to modulate cortisol secretion patterns, reducing the elevated nighttime cortisol that disrupts sleep in stressed individuals Serotonin pathway involvement: DSIP influences serotonergic neurotransmission, which plays a role in sleep onset and maintenance Stress buffering: By reducing the physiological stress response, DSIP helps create the neurochemical conditions favorable for sleep initiation and maintenance Research by Schneider-Helmert and Schoenenberger demonstrated that DSIP administration improved sleep quality in patients with chronic insomnia, with particular improvement in sleep onset latency and time spent in deep sleep stages.[2] Clinical Evidence Chronic Insomnia Studies Clinical studies have shown that DSIP improves multiple sleep parameters in patients with chronic insomnia, including reduced time to fall asleep, increased total sleep time, and improved subjective sleep quality ratings.[2] Stress-Related Sleep Disruption DSIP has demonstrated particular efficacy in stress-related sleep disturbances
Cost and transparency : There should be transparency in the cost of the treatment and how often you will need it
Reminiscent of the early experiences of some GLP-1 drug users, including retatrutide, feeling tired or mood shifts shortly after initiation can be associated with cortisol fluctuations
At Klinic, we believe effective weight loss treatment should be approachable to all, without financial barriers
doi: 10.3389/fendo.2019.00260 Received 12 February 2019 Accepted 08 April 2019 Published 26 April 2019 Volume 10 - 2019 Edited by Ross Bathgate, Florey Institute of Neuroscience and Mental Health, Australia Reviewed by Linda Jane Fothergill, Florey Institute of Neuroscience and Mental Health, Australia
